BRIEF-Protillion Biosciences Announces Drug Discovery Collaboration With Merck

Merck & Co., Inc.

Merck & Co., Inc.

MRK

0.00

June 16 (Reuters) - Merck & Co Inc MRK.N:

  • PROTILLION BIOSCIENCES ANNOUNCES DRUG DISCOVERY COLLABORATION WITH MERCK

  • PROTILLION BIOSCIENCES: UNDER TERMS OF AGREEMENT, PROTILLION WILL RECEIVE AN UNDISCLOSED UPFRONT PAYMENT

  • PROTILLION BIOSCIENCES: UNDER TERMS, CO ELIGIBLE TO RECEIVE MILESTONE PAYMENTS OF UP TO $510 MILLION FOR SUCCESSFUL DEVELOPMENT OF MULTIPLE THERAPIES

Source text: ID:nBw6t6YbWa

Further company coverage: MRK.N


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.